Zobrazeno 1 - 10
of 87
pro vyhledávání: '"T. V. Sleptsova"'
Autor:
T. V. Sleptsova, E. I. Alexeeva, K. V. Savostyanov, A. A. Pushkov, T. M. Bzarova, K. B. Isaeva, R. V. Denisova
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 4, Pp 399-403 (2016)
The article presents an observation of one of the most common autoinflammatory syndromes — TRAPS (periodic syndrome associated with a mutation in the TNF α receptor gene). During a molecular-genetic examination of a 9-year-old child, a c.337_339de
Externí odkaz:
https://doaj.org/article/63fb2ce544ec452dbf94752420e34d2a
Autor:
E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 4, Pp 390-394 (2016)
This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal ant
Externí odkaz:
https://doaj.org/article/9e4fa09829bf4dbabbd00d6090e2ddd7
Autor:
T. V. Sleptsova, E. I. Alexeeva, K. V. Savost’yanov, A. A. Pushkov, T. M. Bzarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 2, Pp 143-148 (2016)
The article shows the observation of rare NLPC4-associated autoinflammatory syndrome with enterocolitis and familial cold urticaria. Diagnosis is confirmed molecularly-genetically: previously not described mutation c.928C>T in the heterozygous state
Externí odkaz:
https://doaj.org/article/02d2b0c5e3464d21b2c28ffab04d2102
Autor:
T. M. Bzarova, Ye. I. Alekseeva, S. I. Valieva, R. V. Denisova, K. B. Isaeva, Ye. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, A. N. Fetisova, O. L. Lomakina, M. A. Soloshenko
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 6, Pp 652-660 (2016)
Background: At present, it is urgent to find ways to overcome the inefficiency of and intolerance to the methotrexate therapy in patients with juvenile idiopathic arthritis (JIA). A promising method is the use of TNF-alpha inhibitors as monotherapy.O
Externí odkaz:
https://doaj.org/article/684f62cda9f84b2cabbdfa4088cfb0f0
Autor:
E. A. Ligostaeva, N. A. Curikova, E. I. Alekseeva, S. E. Valieva, T. M. Bzarova, T. V. Sleptsova
Publikováno v:
Педиатрическая фармакология, Vol 12, Iss 4, Pp 467-470 (2015)
The article describes a case of polyarticular juvenile idiopathic arthritis lesions of the cervical spine. This clinical example demonstrates the high efficiency of tocilizumab in a patient with polyarticular juvenile idiopathic arthritis with lesion
Externí odkaz:
https://doaj.org/article/795ea16d4fc54035b94f2e6ad23af8e6
Autor:
T. V. Sleptsova, E. I. Alekseeva, K. V. Savostianov, A. A. Pushkov, T. M. Bazarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Publikováno v:
Педиатрическая фармакология, Vol 12, Iss 4, Pp 456-561 (2015)
The article presents the monitoring of a severe course of CINCA/NOMID syndrome diagnosed at late stages. The use of monoclonal antibodies to IL 1 — kanakinumabum — in a patient with chronic neurological cutaneous and articular syndrome was succes
Externí odkaz:
https://doaj.org/article/9ae97665029648699710b33facbddec0
Autor:
E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, N. I. Taibulatov, A. N. Fetisova, M. Sh. Shingarova
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 464-476 (2015)
Background: Treatment of patients with juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology.Objective: Our aim was to evaluate the efficacy and safety of adalimumab therapy combined with immunosuppressant
Externí odkaz:
https://doaj.org/article/69be06a3af994846b8c5ae690962d944
Autor:
T. M. Bzarova, E. I. Alexeeva, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, A. N. Fetisova, N. I. Taibulatov
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 489-496 (2015)
Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy
Externí odkaz:
https://doaj.org/article/a820173d736749ee9b2272057a066d77
Autor:
A. A. Baranov, E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, R. V. Denisova, T. V. Sleptsova, A. N. Fetisova, O. L. Lomakina
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 2, Pp 224-235 (2015)
Treatment of juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology. Objective: We undertook a study to evaluate the effectiveness and safety of long-term therapy with etanercept in patients with JIA withou
Externí odkaz:
https://doaj.org/article/b24614b13bea42e49b3806b11d2c0dc4
Autor:
K. B. Isaeva, E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova, Т. М. Bzarova, S. I. Valieva, E. V. Mitenko, E. G. Chistyakova, А. М. Chomakhidze
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 4, Pp 156-161 (2014)
The case of early debut and heavy course of juvenile idiopathic arthritis in the patient at the age of 1 year and 8 months, associated with uveitis refractory to the therapy by methotrexate and nonsteroid antiinflammatory preparations is presented. T
Externí odkaz:
https://doaj.org/article/0c94d7663ca6468cb8ac9e38e5faf23a